Figure S3. nuclear and cytosol proteins were isolated from LN229 cells. The expression levels of ITGB4 and KLF4 were detected by western blotting. PARP was used as nuclear marker and GAPDH was used as cytoplasm marker. (TIF 39 kb
Table S1. Detailed information of antibodies used in the study. Table S2. Clinicopathologic characte...
Glial cells exposed to GBM CM do not change the expression of senescence-associated secretory phenot...
Isolation and identification of GSCs. A. a, c: Cells grew into spheres in serum-free medium. b, d: S...
Figure S2. (A-D) ITGB4 was knocked down in LN229 and U251 cells using shRNA. The expression levels o...
Figure S1. (A) ITGB4 mRNA expression in brain tissues (n = 23) and diffuse astrocytoma tissues (n = ...
Figure S3. Nuclear translocation of β-catenin in response to Wnt3a and GSK3i. Immunoblotting shows ...
Additional file 1. Fig. S1: Isolation and validation of patient derived glioma stem cells (GSCs). a ...
Figure S2. Differentiation markers are induced upon CIN depletion. (A) and (B) Real-time PCR of the ...
Table S1. KEGG pathway analysis for genes upregulated in ID8-KRAS-3D cells compared to ID8-3D cells....
The differential expressive genes between U87 and U251 glioma cell lines. (A) Heatmap showed the dif...
Figure S3. (a) Representative western blot (left) and quantification (right) of three separate exper...
Figure S2. Nuclear Protein Marker Localization in mouse and human cell lines. A) Localization of ZC3...
ARHI over-expresssion can inhibit proliferation of glioma stem cells. (a) Fluorescence microscopy of...
FACS analysis showing that both KAT-4 and Capan-2 tumor cells expressed αvβ6 integrin on their cell ...
TAGLN2 regulates mesenchymal markers in primary GBM cells. (A) Knocking down TAGLN2 in mesenchymal G...
Table S1. Detailed information of antibodies used in the study. Table S2. Clinicopathologic characte...
Glial cells exposed to GBM CM do not change the expression of senescence-associated secretory phenot...
Isolation and identification of GSCs. A. a, c: Cells grew into spheres in serum-free medium. b, d: S...
Figure S2. (A-D) ITGB4 was knocked down in LN229 and U251 cells using shRNA. The expression levels o...
Figure S1. (A) ITGB4 mRNA expression in brain tissues (n = 23) and diffuse astrocytoma tissues (n = ...
Figure S3. Nuclear translocation of β-catenin in response to Wnt3a and GSK3i. Immunoblotting shows ...
Additional file 1. Fig. S1: Isolation and validation of patient derived glioma stem cells (GSCs). a ...
Figure S2. Differentiation markers are induced upon CIN depletion. (A) and (B) Real-time PCR of the ...
Table S1. KEGG pathway analysis for genes upregulated in ID8-KRAS-3D cells compared to ID8-3D cells....
The differential expressive genes between U87 and U251 glioma cell lines. (A) Heatmap showed the dif...
Figure S3. (a) Representative western blot (left) and quantification (right) of three separate exper...
Figure S2. Nuclear Protein Marker Localization in mouse and human cell lines. A) Localization of ZC3...
ARHI over-expresssion can inhibit proliferation of glioma stem cells. (a) Fluorescence microscopy of...
FACS analysis showing that both KAT-4 and Capan-2 tumor cells expressed αvβ6 integrin on their cell ...
TAGLN2 regulates mesenchymal markers in primary GBM cells. (A) Knocking down TAGLN2 in mesenchymal G...
Table S1. Detailed information of antibodies used in the study. Table S2. Clinicopathologic characte...
Glial cells exposed to GBM CM do not change the expression of senescence-associated secretory phenot...
Isolation and identification of GSCs. A. a, c: Cells grew into spheres in serum-free medium. b, d: S...